General Information of the Compound
Compound ID |
CP0039375
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepin-6-one
Show/Hide
|
||||||||||||||||||
Synonyms |
11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one & PRO 140 (Anti-CCR5 monoclonal antibody)
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one
BI RG 587
BI-RG-587
BI-RG-587 & CD4-IgG
BIRG 0587
BIRG 587
BIRG-0587
BIRG-587
BIRG587
Cahill May Roberts Brand of Nevirapine
N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin
NEV
NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE
NVP
Nevirapine
Nevirapine & CD4-IgG
Nevirapine & PRO 140
Nevirapine (JAN/USP/INN)
Nevirapine [USAN:INN]
Promeco Brand of Nevirapine
Viramune
Viramune (TN)
Viramune(TM)
Viramune, BI-RG 587, Nevirapine
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C15H14N4O
|
||||||||||||||||||
Molecular Weight |
266.304
|
||||||||||||||||||
Canonical SMILES |
Cc1ccnc2N(C3CC3)c3ncccc3C(=O)Nc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)
Show/Hide
|
||||||||||||||||||
InChIKey |
NQDJXKOVJZTUJA-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
129618-40-2
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06109, Geminin
Protein ID: PT00549, Reverse transcriptase
Cell-based Assay
Protein ID: PT00005, Reverse transcriptase/RNaseH
Cell-based Assay
Biochemical Assays
Cell Viability or Cytotoxicity Assay
Cell Line ID | Cell Line Name | Cell Line Organism | |
CL000247 | MT-4 | Homo sapiens (Human) | 3 |
1 |
CC50 > 7500 nM
|
TI
LI
LO
TS
|
|
---|---|---|---|
2 |
CC50 > 15000 nM
|
TI
LI
LO
TS
|
|
3 |
CC50 > 200000 nM
|
TI
LI
LO
TS
|
Clinical Information about the Compound